SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001485003-18-000075
Filing Date
2018-05-21
Accepted
2018-05-21 14:21:33
Documents
16
Period of Report
2018-05-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ebio-form8xkauapresentatio.htm 8-K 30662
2 EXHIBIT 99.1 vistaauapresentation2018.htm EX-99.1 18906
3 vistaauapresentation2018001.jpg GRAPHIC 70526
4 vistaauapresentation2018002.jpg GRAPHIC 26514
5 vistaauapresentation2018003.jpg GRAPHIC 81902
6 vistaauapresentation2018004.jpg GRAPHIC 100647
7 vistaauapresentation2018005.jpg GRAPHIC 86555
8 vistaauapresentation2018006.jpg GRAPHIC 94870
9 vistaauapresentation2018007.jpg GRAPHIC 59302
10 vistaauapresentation2018008.jpg GRAPHIC 76326
11 vistaauapresentation2018009.jpg GRAPHIC 81874
12 vistaauapresentation2018010.jpg GRAPHIC 78383
13 vistaauapresentation2018011.jpg GRAPHIC 67510
14 vistaauapresentation2018012.jpg GRAPHIC 114609
15 vistaauapresentation2018013.jpg GRAPHIC 78540
16 vistaauapresentation2018014.jpg GRAPHIC 44949
  Complete submission text file 0001485003-18-000075.txt   1515803
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 18849180
SIC: 2834 Pharmaceutical Preparations